Tarsus Q2 net sales climb 69% to USD 173.9 million
TARS•Q2 net sales and cash position
Tarsus posted Q2 net sales of USD 173.9 million, up 69% year over year.
Cash and cash equivalents totaled USD 449.7 million at quarter-end, inclusive of marketable securities.
Guidance raised and Alkeus acquisition agreed
Tarsus lifted its 2026 net sales guidance to USD 685 million to USD 705 million; gross margin is seen at about 83%.
The company reiterated 2026 SG&A expense guidance of USD 545 million to USD 565 million and its R&D expense outlook of USD 160 million to USD 210 million.
Tarsus also agreed to acquire Alkeus with USD 450 million in upfront consideration, split 60% cash and 40% stock, plus up to USD 350 million in milestones.
